Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing tigolaner, emodepside and praziquantel, in treating cats with mixed infection with intestinal nematodes, cestodes and/or lungworms

This paper describes a multicentric field study which has evaluated the safety and efficacy of a novel spot on formulation containing emodepside 2.04% w/v, praziquantel 8.14% w/v and tigolaner 9.79% w/v (Felpreva®, Vetoquinol) when administered at the intended commercial dose of 0.15 ml/kg body weig...

Descripción completa

Detalles Bibliográficos
Autores principales: Cvejić, Dejan, Mencke, Norbert, Petry, Gabriele, Ringeisen, Hannah, Hamburg, Hannah, Hellmann, Klaus, Traversa, Donato, Morelli, Simone, Di Cesare, Angela, Diakou, Anastasia, Farkas, Róbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles from the special issue on Felpreva®: A novel spot-on formulation containing tigolaner, emodepside and praziquantel for parasite control for cats, Edited by Drs Luis Cardoso and Aneta Kostadinova
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382413/
https://www.ncbi.nlm.nih.gov/pubmed/35991086
http://dx.doi.org/10.1016/j.crpvbd.2022.100098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382413/
https://www.ncbi.nlm.nih.gov/pubmed/35991086
http://dx.doi.org/10.1016/j.crpvbd.2022.100098

Ejemplares similares